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18Fluorodeoxyglucose Positron
Emission Tomography Imaging of Atherosclerotic
Plaque Inflammation Is Highly Reproducible
Implications for Atherosclerosis Therapy Trials
James H. F. Rudd, MD, PHD,* Kelly S. Myers, BS,* Sameer Bansilal, MD,† Josef Machac, MD,‡
Ash Rafique, BS,‡ Michael Farkouh, MD, MSC,† Valentin Fuster, MD, PHD,§
Zahi A. Fayad, PHD, FACC, FAHA*
New York, New York
Objectives This study tested the near-term reproducibility of 18fluorodeoxyglucose positron emission tomography (FDG-PET)
imaging of atherosclerosis.
Background It is known that FDG-PET can measure inflammation within the aorta, carotid, and vertebral arteries with histo-
logic validation in humans and animal models of disease. By tracking changes in inflammation over time, PET
could be used as a surrogate marker of antiatheroma drug efficacy. However, the short-term variability and re-
producibility of the technique are unknown.
Methods We imaged the carotid arteries and aorta in 11 subjects with FDG-PET/computed tomography twice, 14 days
apart. We assessed interobserver and intraobserver agreement and interscan variability.
Results Interscan plaque FDG variability over 2 weeks was very low; intraclass correlation coefficients (ICC) ranged between
0.79 and 0.92. Interobserver agreement was high across all territories imaged except aortic arch (ICC values from
0.90 to 0.97, arch 0.71). Intraobserver agreement was high, with ICC values between 0.93 and 0.98.
Conclusions Spontaneous change in plaque FDG uptake is low over 2 weeks, with favorable inter- and intraobserver agree-
ment. Power calculations suggest that drug studies using FDG-PET imaging would require few subjects com-
pared with other imaging modalities. This study strengthens the case for FDG-PET as a noninvasive plaque imag-
ing technique. (J Am Coll Cardiol 2007;50:892–6) © 2007 by the American College of Cardiology Foundation
ublished by Elsevier Inc. doi:10.1016/j.jacc.2007.05.024r
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stherosclerosis is a global epidemic and likely to become
he leading cause of death worldwide by 2010. Clinical
vents attributable to plaque rupture are related to the level
f plaque inflammation.
Nevertheless, several drugs are expected to improve the
utlook over the next decade. Unfortunately, testing new
reatments requires large trials with clinical end points.
herefore, drug developers need early markers of drug
fficacy before beginning costly trials. The use of imaging
or this role has been suggested (1).
rom the *Imaging Science Laboratories, †Cardiovascular Imaging Clinical Trials
nit, ‡Division of Nuclear Medicine, Department of Radiology, and §The Zena and
ichael A. Wiener Cardiovascular Institute and Marie-Josee and Henry R. Kravis
ardiovascular Health Center, Mount Sinai School of Medicine, New York, New
ork. This study is supported by the National Institutes of Health (grants R01
L71021R01, R01 HL78667) and by an unrestricted research grant from Glaxo-
mithKline. Dr. Rudd is an International Fellowship holder from the British Heart
oundation.F
Manuscript received February 19, 2007; revised manuscript received May 9, 2007,
ccepted May 14, 2007.18Fluorodeoxyglucose (FDG) positron emission tomog-
aphy (PET) is firmly established in oncology for monitor-
ng the response of tumors to treatment (2), and it was
hown in 2002 (3) that FDG-PET imaging could image
etabolic activity within carotid atherosclerosis as a marker
f plaque inflammation. Others have expanded on this work
y imaging the vertebral arteries (4) and aorta (5). Tawakol
6) showed a positive correlation between carotid plaque
DG uptake and macrophage content. Animal work (7)
emonstrated that plaque inflammation can be reduced by
robucol and quantified using FDG-PET. In the first
uman study of its kind (8), FDG-PET was used to
onitor reduction in carotid plaque inflammation during
tatin therapy.
However, more information is still required. First, the
ear-term reproducibility of plaque PET/computed tomog-
aphy (CT) imaging is unknown. Second, both interob-
erver and intraobserver agreements have not been tested.
inally, we need to define the mean and standard deviation
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August 28, 2007:892–6 Reproducibility of Atherosclerosis PET Imagingf plaque FDG measurements in different vascular beds.
his knowledge will allow the calculation of sample sizes for
dequately powered drug studies.
We tested the interscan variability of FDG-PET imaging
y scanning 11 subjects twice within 2 weeks and measuring
he interobserver and intraobserver agreement of the
echnique.
ethods
tudy population. We recruited 11 subjects with established
ascular disease or elevated Framingham risk scores from
ount Sinai Medical Center. Subjects gave written con-
ent, and the study was approved by the local Institu-
ional Review Board.
ET/CT imaging. Subjects underwent 2 PET/CT scans 2
eeks apart (scan 1 and scan 2) on a GE (Milwaukee,
isconsin) Lightspeed PET/CT scanner. Subjects with a
rescan glucose level of 200 mg/dl were excluded. Flu-
rodeoxyglucose was injected, and patients rested for 90
in. Aortic imaging was performed first, with a CT scan for
ocalization and attenuation correction. The aortic arch was
he upper limit of the scan, which covered 3 bed positions in
-dimensional (2D) mode for 10 min each. Next, subjects
ere placed into a head holder, and a single-bed position
Figure 1 Mean TBR Values at First and Second Scan
Error bars indicate standard deviation. Little spontaneous change in tissue-to-
background ratio (TBR) values between the two scans is noted. *p  0.05 for
the TBR of both left and right carotid artery compared with the TBR of all aortic
regions. Abd  abdominal; Asc  ascending; Desc  descending.
BR Variability Over 2 Weeks
Table 1 TBR Variability Over 2 Weeks
Ascending Aorta Arch of Aorta
Scan 1 TBR 1.39 (0.18) 1.31 (0.16)
Scan 2 TBR 1.38 (0.17) 1.31 (0.12)
TBR difference 0.01 (0.07) 0.0005 (0.06)
95% normal range for change 0.14 0.12ean (SD). Tissue-to-background ratio (TBR) values for scan 1 and 2 and the differences and 95% normaarotid PET scan was performed
n 3-dimensional (3D) mode for
5 min. For carotid imaging, the
canner was found to perform
est in 3D mode compared to
D mode, giving images of
reater uniformity, resolution,
nd sensitivity. However, when
D-mode imaging of the aorta
as attempted, significant signal
ropout artifacts were sometimes
oted, probably because of high
DG uptake in adjacent struc-
ures causing dead-time issues.
herefore, we reverted to 2D-
ode aortic imaging.
mage analysis. Image analysis
as performed on a Xeleris
orkstation. The aorta was di-
ided into ascending, arch, and
escending segments using CT
mages. Arterial FDG uptake was quantified by drawing a
egion of interest (ROI) around each artery on every slice of
he coregistered transaxial PET/CT images. Next, the
rterial standardized uptake value (SUV) was calculated as
he mean pixel activity within the ROI.
By averaging the SUV values for each artery slice, we
erived a mean SUV value for the entire artery (arterial SUV).
his was corrected for blood activity by division by the average
lood SUV estimated from either the inferior vena cava or
ugular vein to produce a blood-corrected artery SUV, known
s the arterial tissue-to-background ratio (TBR) (6).
esting intraobserver and interobserver agreement. An
xperienced reader (J.R.) analyzed all studies (scan 1 and
can 2) in every subject. Additionally, intraobserver agree-
ent was assessed. Scan 1 studies of all 11 subjects were
ead a second time by the same reader. To reduce recall bias,
he second reading took place at least 1 month after the first
eading. After a period of joint working on pilot images (not
ncluded in this study) to establish methods of analysis and
ecording, interobserver agreement was tested. All 11 pa-
ients’ first PET scans (scan 1) were independently read by
nother reader (K.M.). The studies were presented in a
andom order.
tatistical methods. Continuous variables are expressed as
ean  SD. Paired 2-sided t tests were used to check for
ending Aorta Abdominal Aorta Left Carotid Right Carotid
1.23 (0.16) 1.30 (0.12) 1.55 (0.28) 1.64 (0.25)
1.24 (0.14) 1.29 (0.12) 1.56 (0.24) 1.62 (0.23)
.084 (0.10) 0.01 (0.08) 0.0097 (0.12) 0.0201 (0.11)
0.20 0.16 0.24 0.22
Abbreviations
and Acronyms
CT  computed
tomography
FDG 
18fluorodeoxyglucose
ICC  intraclass
correlation coefficient
MRI  magnetic resonance
imaging
PET  positron emission
tomography
ROI  region of interest
SUV  standardized uptake
value
TBR  tissue-to-
background ratio
2D  2-dimensional
3D  3-dimensionalDesc
0l ranges for ‘allowable’ change in TBR between scans over a 2-week period.
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Reproducibility of Atherosclerosis PET Imaging August 28, 2007:892–6ifferences between mean values of continuous variables. In
his study, corrections for multiple comparisons were not
pplied. The 95% normal ranges for TBR differences
etween scans 1 and 2 were estimated by doubling the
tandard deviation of the mean difference between the 2
cans (9). A p value of 5% was considered statistically
ignificant.
Power analyses were based on a 2-sample unpaired t test
2-sided) and performed with 80% power and an alpha of
%.
Intraclass correlation coefficients (ICC) (10) with 95%
onfidence intervals were calculated to test the interscan
ariability and also to assess interobserver and intraobserver
greement. An ICC value of 1 indicates perfect agreement,
ith random or systematic differences between the 2 mea-
urements decreasing the value.
Bland-Altman plots were also used to assess interob-
erver, intraobserver, and interscan variability. Statistical
nalysis was performed using SPSS version 14 (SPSS Inc.,
hicago, Illinois).
esults
atient characteristics. Eleven asymptomatic patients
ere imaged twice, 14 days apart. Mean age was 64.6  7.3
Figure 2 Carotid and Aortic PET/CT Images Over 2 Weeks
(A) Axial images from scan 1 and 2 of one subject’s carotid artery. Computed tom
(right) with arrows indicating similar 18fluorodeoxyglucose (FDG) uptake in the righ
subject’s aorta. CT (left), PET (middle), and fused PET/CT (right) with arrows indi
ntraclass Correlation Coefficient Values (95% Confidence Intervals
Table 2 Intraclass Correlation Coefficient Values (95% Confide
Ascending Aorta Arch of Aorta De
Interobserver agreement 0.92 (0.70–0.98) 0.71 (0.05–0.92) 0.
Intraobserver agreement 0.98 (0.94–1.00) 0.96 (0.85–0.99) 0.Interscan variability 0.92 (0.75–0.98) 0.91 (0.72–0.98) 0.80 (0.4ears, and there were 4 women. All patients had atheroscle-
osis or elevated risk scores (2 previous transient ischemic
ttack, 8 coronary artery disease with prior revascularization,
nd 1 subject with prior myocardial infarction). Five subjects
ad type 2 diabetes.
maging parameters. The FDG doses were similar across
oth scans (mean scan 1: 572  54 MBq, mean scan 2:
92  46 MBq, p  0.27). Aortic imaging commenced
6.6  12.3 min after injection and was not different
etween scans (mean scan 1: 95.7 10.6 min, mean scan 2:
7.5  14.3 min, p  0.37). Similarly, mean start time for
arotid imaging was 145.7  16.1 min, with no significant
ifference between scans (148.0  16.2 min and 143.5 
6.6 min, p  0.52). No patient reported any symptom or
edication change between scans.
Mean TBR values are given in Figure 1. The carotid
rteries both had significantly higher TBR values than all
ortic territories (scan 1 data: carotid vs. ascending aorta
 0.05, vs. arch p  0.005, vs. descending aorta p 
.0005, and vs. abdominal aorta p  0.001). There was no
ignificant difference between the left and right carotid
rteries (scan 1: left carotid TBR 1.55  0.28, right carotid
BR 1.64  0.25, p  0.44). The carotid TBR values are
sed for sample size calculations in the discussion.
hy (CT) (left), positron emission tomography (PET) (middle), and fused PET/CT
tid artery at both time points. (B) Sagittal images from scan 1 and 2 of another
similar FDG uptake in the aortic arch and descending aorta at both time points.
arentheses)
ntervals in Parentheses)
ing Aorta Abdominal Aorta Left Carotid Right Carotid
8–1.00) 0.90 (0.10–0.98) 0.97 (0.89–0.99) 0.97 (0.91–0.99)
7–0.98) 0.94 (0.81–0.98) 0.95 (0.83–0.99) 0.98 (0.93–0.99)ograp
t caro
catingin P
nce I
scend
97 (0.8
93 (0.73–0.94) 0.79 (0.40–0.93) 0.90 (0.70–0.97) 0.90 (0.68–0.97)
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August 28, 2007:892–6 Reproducibility of Atherosclerosis PET ImagingTable 1 shows interscan variability data and gives mean
BR values for all arterial territories for scans 1 and 2, 2
eeks apart, along with the TBR differences and estimated
5% normal ranges for change. It is clear that there is very
ittle spontaneous variation in FDG signal over 2 weeks.
his is illustrated in Figure 2, with carotid and aortic images
f 2 patients in whom little appreciable change in FDG
ptake can be seen between scan 1 and scan 2.
Table 2 shows the ICCs, with 95% confidence intervals for
nterobserver, intraobserver, and interscan variability. All ICC
alues except 2 are 0.8 (an accepted marker of excellent
greement [10]), with generally narrow confidence intervals.
Bland-Altman plots demonstrated no evidence of either
xed or proportional bias. Figure 3 shows plots for the right
arotid artery. Most of the data points fall within the narrow
imits of agreement.
iscussion
e prospectively tested the reproducibility of FDG-PET
nflammation imaging in atherosclerosis and showed high
eproducibility over 2 weeks in the aorta and carotid arteries.
dditionally, inter- and intraobserver agreement measure-
ents are favorable, with the exception of the aortic arch.
his territory had only moderate interobserver agreement,
ikely because of its complex geometry, making accurate
lacement of similar ROIs difficult for independent readers.
e recommend using the carotid artery or ascending aorta
n future studies; these areas had the best reproducibility and
greement statistics.
We provided mean and SD values for aorta and carotid
BR values. This information makes it possible to estimate
ubject numbers for drug trials. An illustration of sample sizes
equired at different levels of estimated drug effects is provided
n Figure 4, based on right carotid TBR data from scan 1. As
result of low standard deviation values, PET imaging requires
ew subjects to show significant differences between groups.
hese estimates should be interpreted with caution, however,
ecause they assume a perfect agreement between TBR signal
hange and underlying change in plaque inflammation, which
ay not be the case. Nevertheless, they do provide a frame-
ork for minimum sample sizes.
We also measured the interscan TBR differences over 2
eeks and established normal ranges of TBR variability for
ach arterial territory (twice the standard deviation of the
ifference between scan 1 and scan 2); any change of TBR
utside this limit after a therapeutic intervention may be
nterpreted as a drug effect. For example, in a hypothetical
ET/CT trial of a novel anti-inflammatory atherosclerosis
herapy, a change in mean TBR in the ascending aorta of
.14 or more between scan 1 and scan 2 would occur by
hance 5% of the time, and we could be 95% confident
hat it was occurring as a result of a drug effect. study limitations Some of the difference in TBR between
arotid and aorta could be accounted for by the different
Figure 3 Bland-Altman Plots of Interobserver,
Intraobserver, and Interscan Variability
(A) Interobserver, (B) intraobserver, and (C) interscan variability. The dashed line
is the mean difference between the 2 scans, while the limits of agreement are
drawn as solid lines (mean difference  2 SD). TBR  tissue-to-background ratio.can acquisition times, although this effect is likely to be
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Reproducibility of Atherosclerosis PET Imaging August 28, 2007:892–6mall because of the small absolute values of the TBR
easurements.
omparison with other techniques. These PET repro-
ucibility measurements compare well with other athero-
clerosis imaging techniques such as magnetic resonance
maging (MRI) (11), intravascular ultrasound (12), and CT
13). Additionally, the high sensitivity of FDG-PET allows
etection of small metabolic changes within plaque that
ccur before structural alterations can be detected by other
odalities. For example, a recent study administered sim-
astatin 40 mg daily to reduce plaque inflammation and
ompared it with diet alone in oncology patients. We found
hat FDG-PET detected the positive effect of therapy
ithin 3 months (8). However, using the same drug in a
igher dose, another group imaged plaque area regression
ith MRI (14). These investigators were not able to see an
ffect by MRI until 12 months.
onclusions
e have shown that FDG-PET meets 2 important criteria
or serial atherosclerotic plaque imaging. First, spontaneous
hanges in plaque FDG uptake are low over 2 weeks.
econd, interobserver agreement is excellent, meaning that
Figure 4 Sample Size Estimates Based on Drug Efficacy
The number of subjects needed in trials using 18fluorodeoxyglucose
positron emission tomography is shown for several levels of drug effect.ongitudinal multicenter trials of drugs are now feasible.eprint requests and correspondence: Dr. James H. F. Rudd, ACCI
evel 3, Addenbrookes Hospital, Cambridge CB2 2QQ, United King-
om. E-mail: jhfr2@cam.ac.uk and/or zahi.fayad@mssm.edu.
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